New Podcast Episode by PharmaSources!

[Pharma Sources]

View this E-mail (https://info.cphi-chinaedm.com/x/?S7Y1Mf2fa2tsYG5g8D.H1tTQwML4f5GthaGxsZkBAAA05)  (https://info.cphi-chinaedm.com/x/?S7Y1Mf2fa2tsYG5g8D.H1tTQwML4f5GthaGxsZkBAAA05)online

PharmaVibe - capture dynamics of the pharmaceutical industry (https://www.pharmasources.com/pharmavibe/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0907)
WELCOME TO
PharmaVibe
Podcast hosted by PharmaSources

Listen and sense the heartbeat of the pharma industry through news stories, key conferences, and in-depth interviews encompassing an array of specialties, sectors, and areas.
Subscribe Now (https://www.pharmasources.com/pharmavibe/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0907)
PharmaVibe

Latest Release

New Release!

 
ep20 - The First and Only TIGIT/TGFβ Bispecific Antibody Under Research in the World
EPISODE 20 | 16 MIN | 7 September. 2022
#Drug Review   #R&D   #Business   #Listing

The First and Only TIGIT/TGFβ Bispecific Antibody Under Research in the World
The marketing approval of SinoCellTech's new anti-CD20 monoclonal antibody ripertamab aroused the attention of the industry in China this week.

While the clinical trial application of the AK130 injection developed by another Chinese company Akeso was accepted, making it the first and the only TIGIT/TGFβ bispecific antibody under research in the world. 
Play (https://www.pharmasources.com/pharmavibe/detail/20.html/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0907)

 

Featured Webinar

CPHI & PMEC China E-learn Series Webinar: China’s Quality and Therapeutic Equivalence Evaluation of Generic Drug
China’s Quality and Therapeutic Equivalence Evaluation of Generic Drug

22 September   4 pm CET | 10 am EST
Register for Free (https://www.pharmasources.com/zt/cphichinawebinar/equivalence-evaluation-of-generic-drugs?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0907)

  
---------------------------------------------------------------------------------

Facebook (https://www.facebook.com/Pharmasources/?utm_source=EDM&utm_medium=online&am%20p;utm_campaign=enedmpodcast0907)Twitter (https://twitter.com/Pharmachina365/?utm_source=EDM&utm_medium=online&am%20p;utm_campaign=enedmpodcast0907)Linkedin (https://www.linkedin.cn/company/pharmasources?utm_source=EDM&utm_medium=online&am%20p;utm_campaign=enedmpodcast0907)
Customer Service
+86-13621645194
PharmaSources at imsinoexpo.com (mailto:PharmaSources at imsinoexpo.com)
Scan this code to start a Telegram chat with PharmaSources
Telegram
Scan this code to start a WhatsApp chat with PharmaSources
WhatsApp

If you no longer wish to receive our e-mail updates,
please go here to unsubscribe. (https://info.cphi-chinaedm.com/x/plugin/?pName=unsubscribe&MIDRID=S7Y1Mf2fa2tsYG5g8D.H1tTQwML4f5GthaGxsZkBAAA05&Z=1587355152)
   
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.nottingham.ac.uk/pipermail/affymetrix-arabidopsis/attachments/20220907/6480cf06/attachment-0001.html>